Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,230.71
(
-0.16%
)
Brent Oil
100.70
(
-0.82%
)
Bitcoin
79,068.61
(
0.53%
)
News Focus
News Focus
Post# of 97241
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

$heff

Send PM Follow Ignore
Followers 3414
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

$heff

Re: $heff post# 26874

Friday, 04/23/2010 11:23:35 AM

Friday, April 23, 2010 11:23:35 AM

Post# of 97241
POZN (11.00).. Analyst thoughts on POZN and its potential for Vimovo approval!
http://finance.yahoo.com/news/Arthritis-Drug-Vimovo-twst-3473823072.html?x=0&.v=1
Dr. Jonathan Aschoff, Ph.D., is a Senior Equity Analyst at Brean Murray, Carret & Co., LLC



Sheff's Station...All Aboard...Sign Up Here!

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today